Review Article

An assessment of antiretroviral drug initiation to pregnant women of unknown HIV status during labour and delivery in Cameroon

Published in: African Journal of AIDS Research
Volume 17 , issue 3 , 2018 , pages: 265–271

DOI: 10.2989/16085906.2018.1515780

Author(s): Anastasia Yenban Bongajum Ministry of Public Health, Cameroon , Divine Mbiydzenyuy Dufe Merck Animal Health, The Netherlands , Paul Théodore Biyaga Tjek Ministry of Public Health, Cameroon , Daniel Ter Goon Department of Nursing Sciences, , Céline Nguefeu Nkenfou “Chantal Biya” Reference Centre for HIV/AIDS Prevention and Management, Cameroon , Julius Mbekem Nwobegahay Cameroon Military Health Research Center (CRESAR), Cameroon , Robinson Mbu Department of Family Health, Ministry of Public Health, Cameroon

Keywords: ARV initiation , labour and delivery , PMTCT , public and private health facilities , unknown HIV status

Download full text Get new issue alerts

Abstract

Background: Evidence from previous research has shown that antiretroviral (ARV) drug initiation to seropositive pregnant women could significantly contribute to eliminating new paediatric infections even when started during labour and delivery. This study therefore seeks to assess missed opportunities for ARV initiation during this critical period of pregnancy to improve outcomes of the prevention of mother-to-child transmission (PMTCT) programmes in Cameroon.

« Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia

Courage and confidence to stop lying: caregiver perspectives on a video to support paediatric HIV disclosure in Kampala, Uganda »